-

01:52:54 AM

CDNA Stock News

CDNA - Caredx Inc

12/13/21 7:00 AM

Nasdaq : CDNA

partnership

CareDx Partners with the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) Organization in Launching Prospective, Multi-Center Pediatric Kidney Transplant Study

CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company focused on the discovery, development and

RHEA-AI

neutral

12/02/21 7:00 AM

Nasdaq : CDNA

CareDx The Transplant Company Surpasses 80,000 Patient Milestone

CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company focused on the discovery, development and

RHEA-AI

neutral

11/19/21 7:00 AM

Nasdaq : CDNA

CareDx Named One of the Fastest-Growing Companies in North America on the Deloitte Technology Fast 500™ for the Third Consecutive Year

The Transplant Company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced

RHEA-AI

very positive

11/18/21 7:00 AM

Nasdaq : CDNA

CareDx Enrolls First Patients in the Largest Digital Study in Transplant Using AlloCare to Assess Patient Outcomes

CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company focused on the discovery, development, and commercialization of clinically differentiated, high-value

RHEA-AI

neutral

11/15/21 4:05 PM

Nasdaq : CDNA

conferences

CareDx To Participate in Upcoming Conferences

CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers,

RHEA-AI

neutral

11/10/21 7:00 AM

Nasdaq : CDNA

acquisition

CareDx Acquires MedActionPlan to Directly Support Patients with Better Adherence

CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the

RHEA-AI

neutral

11/04/21 7:00 AM

Nasdaq : CDNA

University of Alabama Integrates CareDx’s TxAccess for Connection to Over 500 Community Practices

CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated,

RHEA-AI

neutral

11/03/21 7:00 AM

Nasdaq : CDNA

CareDx Focuses on Innovation in Transplant at ASN Kidney Week

CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery,

RHEA-AI

neutral

11/01/21 4:01 PM

Nasdaq : CDNA

management

CareDx Completes Orderly Management Transition

CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today

RHEA-AI

neutral

10/28/21 4:01 PM

Nasdaq : CDNA

CareDx Reports Third Quarter 2021 Results; Increases Full Year Revenue Guidance

CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today

RHEA-AI

neutral

Prev 1 2 3 4 5 6 7 8 9 10 Next

CDNA Data

IndustryMedical Laboratories
Websitewww.caredx.com
CeoPeter Maag
Security nameCaredx Inc
Issue typecs
SectorHealth Care and Social Assistance
Sic code8071
Employees466
Tags
- Health Technology
- Medical Specialties
- Health Care and Social Assistance
- Medical Laboratories
Address1 Tower Place
Address29Th Floor
StateCalifornia
CitySouth San Francisco
Zip94080
CountryUS
Phone14152872300

About Caredx Inc

CareDx, Inc., headquartered in South San Francisco, California, is a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the leading provider of genomics-based information for transplant patients.